651 - 700 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Overcoming obstacles in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 13Start Page: 1606End Page: 1611Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25260Citation Count: 44
-
RESTRICTEDTitle: Gait impairments in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 7Start Page: 697End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30044-4Citation Count: 399
-
RESTRICTEDTitle: Mitochondria at the interface between neurodegeneration and neuroinflammationJournal Name: Seminars in Cell & Developmental BiologyPublisher: Elsevier BVVol: 99Issue #:Start Page: 163End Page: 171Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.semcdb.2019.05.028Citation Count: 73
-
RESTRICTEDTitle: A case series and systematic review of rapid eye movement sleep behavior disorder outcome after deep brain stimulation in Parkinson's diseaseJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 77Issue #:Start Page: 170End Page: 176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2020.11.025Best OA location URL: https://boris.unibe.ch/149175/1/Cavalloni__2020__A_case_series_and_systematic_review_of_REM_sleep_behavior_disorder.pdfCitation Count: 10
-
RESTRICTEDTitle: The effects of exercise on sleep quality in persons with Parkinson's disease: A systematic review with meta-analysisJournal Name: Sleep Medicine ReviewsPublisher: Elsevier BVVol: 55Issue #:Start Page: 101384End Page: 101384Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smrv.2020.101384Citation Count: 47
-
RESTRICTEDTitle: Opicapone: A third generation COMT inhibitorJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 4Issue #:Start Page: 100083End Page: 100083Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100083Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100083Citation Count: 15
-
RESTRICTEDTitle: Advances in studying protein disorder with solid-state NMRJournal Name: Solid State Nuclear Magnetic ResonancePublisher: Elsevier BVVol: 106Issue #:Start Page: 101643End Page: 101643Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ssnmr.2020.101643Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202078Citation Count: 28
-
RESTRICTEDTitle: Pharmaceutical Implications of Sex-Related RNA Divergence in Psychiatric DisordersJournal Name: Trends in Pharmacological SciencesPublisher: Elsevier BVVol: 41Issue #: 11Start Page: 840End Page: 850Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.tips.2020.09.003Best OA location URL: http://www.cell.com/article/S0165614720302091/pdfCitation Count: 13
- Parkinson's disease2021RESTRICTEDTitle: Parkinson's diseaseJournal Name: The LancetPublisher: Elsevier BVVol: 397Issue #: 10291Start Page: 2284End Page: 2303Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(21)00218-xBest OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/235670/235670.pdfCitation Count: 1391
-
RESTRICTEDTitle: Long-term unsupervised mobility assessment in movement disordersJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 462End Page: 470Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30397-7Best OA location URL: https://pure.rug.nl/ws/files/121196279/Long_term_unsupervised_mobility_assessment_in.pdfCitation Count: 187
-
RESTRICTEDTitle: Coexistence of deep brain stimulators and cardiac implantable electronic devices: A systematic review of safetyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 129End Page: 135Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.018Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3638884/viewCitation Count: 2
- Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins2021OPENTitle: Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxinsJournal Name: Redox BiologyPublisher: Elsevier BVVol: 41Issue #:Start Page: 101905End Page: 101905Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.redox.2021.101905Best OA location URL: https://doi.org/10.1016/j.redox.2021.101905Citation Count: 4
-
RESTRICTEDTitle: Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100161End Page: 100161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100161Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100161Citation Count: 7
- PLA2G6-associated neurodegeneration in four different populations-case series and literature review2022RESTRICTEDTitle: PLA2G6-associated neurodegeneration in four different populations-case series and literature reviewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 66End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.016Best OA location URL: http://manuscript.elsevier.com/S1353802022002115/pdf/S1353802022002115.pdfCitation Count: 4
-
RESTRICTEDTitle: Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified IndividualsJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 12Start Page: e50640End Page: e50640Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0050640Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0050640&type=printableCitation Count: 53
-
RESTRICTEDTitle: Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/7351985Best OA location URL: http://downloads.hindawi.com/journals/pd/2016/7351985.pdfCitation Count: 24
-
OPENTitle: Improved motion correction for functional MRI using an omnibus regression modelJournal Name: 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/isbi45749.2020.9098688Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990252Citation Count: 2
-
RESTRICTEDTitle: Chaperone-Based Therapies for Disease Modification in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2017Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/5015307Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/5015307.pdfCitation Count: 34
-
RESTRICTEDTitle: What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?Journal Name: PrionPublisher: Informa UK LimitedVol: 7Issue #: 1Start Page: 92End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4161/pri.23806Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/pri.23806?needAccess=trueCitation Count: 54
-
RESTRICTEDTitle: The role of microbial amyloid in neurodegenerationJournal Name: PLOS PathogensPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 12Start Page: e1006654End Page: e1006654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.ppat.1006654Best OA location URL: https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006654&type=printableCitation Count: 272
-
RESTRICTEDTitle: Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestriesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 6Start Page: e0198166End Page: e0198166Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0198166Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0198166&type=printableCitation Count: 83
-
RESTRICTEDTitle: Should Skin Biopsies Be Performed in Patients Suspected of Having Parkinson’s Disease?Journal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2017Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/6064974Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/6064974.pdfCitation Count: 7
-
RESTRICTEDTitle: Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's diseaseJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 83Issue #:Start Page: 20End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2014.02.005Best OA location URL: https://europepmc.org/articles/pmc6075820?pdf=renderCitation Count: 54
-
RESTRICTEDTitle: Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative diseaseJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 114Issue #: 3Start Page: 261End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2007.02.002Best OA location URL: https://europepmc.org/articles/pmc1964795?pdf=renderCitation Count: 94
-
RESTRICTEDTitle: α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 63Issue #: 4Start Page: 938End Page: 966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.110.003269Best OA location URL: https://europepmc.org/articles/pmc3186078?pdf=renderCitation Count: 171
-
RESTRICTEDTitle: Glutamate Receptor Ion Channels: Structure, Regulation, and FunctionJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 62Issue #: 3Start Page: 405End Page: 496Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.109.002451Best OA location URL: https://europepmc.org/articles/pmc2964903?pdf=renderCitation Count: 2923
-
RESTRICTEDTitle: PARkinson's: From cellular mechanisms to potential therapeuticsJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 230Issue #:Start Page: 107968End Page: 107968Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107968Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821123Citation Count: 4
-
RESTRICTEDTitle: Human embryonic stem cells for brain repair?Journal Name: Philosophical Transactions of the Royal Society B: Biological SciencesPublisher: The Royal SocietyVol: 363Issue #: 1489Start Page: 87End Page: 99Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1098/rstb.2006.2014Best OA location URL: https://europepmc.org/articles/pmc2605488?pdf=renderCitation Count: 34
-
RESTRICTEDTitle: The Retina in Multiple System Atrophy: Systematic Review and Meta-AnalysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2017.00206Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2017.00206/pdfCitation Count: 32
-
RESTRICTEDTitle: Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier GenesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2015.00027Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2015.00027/pdfCitation Count: 7
- Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches2015RESTRICTEDTitle: Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted ApproachesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2015.00256Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2015.00256/pdfCitation Count: 15
-
RESTRICTEDTitle: Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2014.00242Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2014.00242/pdfCitation Count: 177
-
RESTRICTEDTitle: Transcranial static magnetic stimulation —From bench to bedside and beyond—Journal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 156Issue #:Start Page: 250End Page: 255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2019.12.005Citation Count: 14
-
RESTRICTEDTitle: Disease modifying therapies for Parkinson's disease: Novel targetsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 201Issue #:Start Page: 108839End Page: 108839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839Citation Count: 4
-
RESTRICTEDTitle: New dopaminergic therapies for PD motor complicationsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 204Issue #:Start Page: 108869End Page: 108869Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108869Citation Count: 8
-
RESTRICTEDTitle: Etiology, pathological characteristics, and clinical management of black pleural effusionJournal Name: MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 8Start Page: e28130End Page: e28130Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1097/md.0000000000028130Best OA location URL: https://doi.org/10.1097/md.0000000000028130Citation Count: 6
-
RESTRICTEDTitle: The genetics of Parkinson diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 42Issue #:Start Page: 72End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.12.007Citation Count: 386
- Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillations2016RESTRICTEDTitle: Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillationsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26837Citation Count: 63
-
RESTRICTEDTitle: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's diseaseJournal Name: Biology of the CellPublisher: WileyVol: 111Issue #: 6Start Page: 161End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/boc.201800068Citation Count: 36
-
RESTRICTEDTitle: Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and PathologyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 1Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20010141Best OA location URL: https://www.mdpi.com/1422-0067/20/1/141/pdf?version=1546425034Citation Count: 55
-
RESTRICTEDTitle: Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 16End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.016Best OA location URL: https://cris.maastrichtuniversity.nl/files/76214281/Leentjens_2019_Resting_state_fMRI_in_Parkinsons.pdfCitation Count: 129
-
RESTRICTEDTitle: Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 7Start Page: 957End Page: 957Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12070957Best OA location URL: https://www.mdpi.com/2218-273X/12/7/957/pdf?version=1657271910Citation Count: 14
- Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?2021RESTRICTEDTitle: Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12010040Best OA location URL: https://www.mdpi.com/2218-273X/12/1/40/pdf?version=1640831739Citation Count: 4
-
RESTRICTEDTitle: Prodromal Cognitive Deficits and the Risk of Subsequent Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 2Start Page: 199End Page: 199Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12020199Best OA location URL: https://www.mdpi.com/2076-3425/12/2/199/pdf?version=1643638610Citation Count: 5
-
RESTRICTEDTitle: A New Rise of Non-Human Primate Models of SynucleinopathiesJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 3Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9030272Best OA location URL: https://www.mdpi.com/2227-9059/9/3/272/pdf?version=1615293914Citation Count: 9
-
RESTRICTEDTitle: LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 11Issue #: 8Start Page: 1101End Page: 1101Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom11081101Best OA location URL: https://www.mdpi.com/2218-273X/11/8/1101/pdf?version=1627473313Citation Count: 26
-
RESTRICTEDTitle: Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient CellsJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 5Start Page: 981End Page: 981Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10050981Best OA location URL: https://www.mdpi.com/2073-4409/10/5/981/pdf?version=1619174268Citation Count: 6
-
RESTRICTEDTitle: Animal Models of Autosomal Recessive ParkinsonismJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 7Start Page: 812End Page: 812Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9070812Best OA location URL: https://www.mdpi.com/2227-9059/9/7/812/pdf?version=1626351984Citation Count: 7
-
RESTRICTEDTitle: Alpha-Synuclein and Lipids: The Elephant in the Room?Journal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2452End Page: 2452Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092452Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2452/pdf?version=1632375393Citation Count: 22
-
RESTRICTEDTitle: Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic OpportunitiesJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 18Start Page: 2908End Page: 2908Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11182908Best OA location URL: https://www.mdpi.com/2073-4409/11/18/2908/pdf?version=1663735802Citation Count: 34